Inhibition of PCSK9 enhances the antitumor effect of PD-1 inhibitor in colorectal cancer by promoting the infiltration of CD8+ T cells and the exclusion of Treg cells
出版年份 2022 全文链接
标题
Inhibition of PCSK9 enhances the antitumor effect of PD-1 inhibitor in colorectal cancer by promoting the infiltration of CD8+ T cells and the exclusion of Treg cells
作者
关键词
-
出版物
Frontiers in Immunology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-08-08
DOI
10.3389/fimmu.2022.947756
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A SIRPαFc Fusion Protein Conjugated With the Collagen-Binding Domain for Targeted Immunotherapy of Non-Small Cell Lung Cancer
- (2022) Jiayang Liu et al. Frontiers in Immunology
- MEK inhibition remodels the immune landscape of mutant KRAS tumors to overcome resistance to PARP and immune checkpoint inhibitors
- (2021) Bin Yang et al. CANCER RESEARCH
- CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability
- (2021) Xingzhe Ma et al. Cell Metabolism
- Immune Checkpoint Inhibitor‐Based Strategies for Synergistic Cancer Therapy
- (2021) Mengying He et al. Advanced Healthcare Materials
- Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling
- (2021) Juanjuan Yuan et al. Protein & Cell
- TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism
- (2021) Stefania Canè et al. Journal for ImmunoTherapy of Cancer
- PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma
- (2021) Shi-Zhe Zhang et al. Experimental Hematology & Oncology
- Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors
- (2021) Shihao Xu et al. IMMUNITY
- PCSK9 Biology and Its Role in Atherothrombosis
- (2021) Cristina Barale et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immune checkpoint inhibitors in melanoma
- (2021) Matteo S Carlino et al. LANCET
- An engineered IL-21 with half-life extension enhances anti-tumor immunity as a monotherapy or in combination with PD-1 or TIGIT blockade
- (2021) Hongchuan Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- PCSK9 regulates the NODAL signaling pathway and cellular proliferation in hiPSCs
- (2021) Meryl Roudaut et al. Stem Cell Reports
- Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages
- (2020) Pan Su et al. CANCER RESEARCH
- CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors
- (2020) Haiping Wang et al. NATURE IMMUNOLOGY
- The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
- (2020) Florent Petitprez et al. Frontiers in Immunology
- Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy
- (2020) Jackie E. Bader et al. MOLECULAR CELL
- PCSK9 Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36
- (2020) Zhiyong Qi et al. CIRCULATION
- Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer
- (2020) Grégoire de Streel et al. Nature Communications
- Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity
- (2020) Alison E. Ringel et al. CELL
- α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas
- (2019) E. Dodagatta-Marri et al. Journal for ImmunoTherapy of Cancer
- Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8+ T Cell-Derived Interferon-γ
- (2019) Chang Liu et al. IMMUNITY
- Immune Checkpoint Inhibitor Toxicities
- (2019) Julian A. Marin-Acevedo et al. MAYO CLINIC PROCEEDINGS
- Treg-mediated acquired resistance to immune checkpoint inhibitors
- (2019) Reem Saleh et al. CANCER LETTERS
- STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade
- (2019) Hannah Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy
- (2019) Hao Liu et al. Journal for ImmunoTherapy of Cancer
- Inhibition of autophagy potentiated the anti-tumor effects of VEGF and CD47 bispecific therapy in glioblastoma
- (2018) Xuyao Zhang et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non–Small Cell Lung Cancer
- (2017) Xuyao Zhang et al. Cancer Immunology Research
- PCSK9 and LDLR degradation
- (2014) Thomas A. Lagace CURRENT OPINION IN LIPIDOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant colon cancer chemotherapy: where we are and where we'll go
- (2010) L. Lombardi et al. CANCER TREATMENT REVIEWS
- Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation
- (2010) Rebecca Lock et al. MOLECULAR BIOLOGY OF THE CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now